Reminiscence Therapy in Individuals With Dementia

Dementia Clinical Trial

Official title: The Effect of Reminiscence Therapy Applied to Individuals With Dementia on Cognitive Functions, Anxiety, Depression and Activities of Daily Living

Status Not yet recruiting

Clinical Trial Summary

It is seen that the use of reminiscence therapy, which is an important non-pharmacological treatment that is used quite frequently in the management of dementia in the world, is not at the desired level in our country, and the studies conducted are mostly interview-based. This research will be carried out with the aim of determining the effect of reminiscence therapy applied to individuals with dementia on cognitive functions, anxiety, depression and activities of daily living. In this study, reminiscence therapy will not be based only on interviews, but a separate activity program that will trigger specific recall/memory for each interview will be included, taking into account the socio-cultural structure in the therapy process.

The research will be conducted in Amasya Suluova Hacı Muammer Koca Nursing Home Elderly Care and Rehabilitation Center, with a pre-test post-test single group, quasi-experimental research design. The sample of the research will consist of 28 participants diagnosed with dementia (mild/moderate), aged 65 and over.

In this research, reminiscence therapies will be carried out once a week for 8 weeks, in sessions of approximately 45 minutes. Research data will be collected between January and March 2024 using the Standardized Mini Mental Test, Geriatric Anxiety Scale, Geriatric Depression Scale and Katz's Activities of Daily Living Index. Data collection forms will be applied twice in total, at the end of the 1st session (pretest) and at the end of the 8th session (posttest).

The data obtained from the research will be analyzed in the Statistical Package for Social Science (SPSS) 21 statistical program. Variables covering the descriptive characteristics of individuals with dementia will be expressed in numbers and percentages. Whether the data has a normal distribution will be determined by the Kolmogrov Smirnov test and parametric and/or nonparametric tests will be used according to the results obtained. Statistical significance value will be accepted as p<.05.

Clinical Trial Description

Dementia; It is a disease that requires intensive use of health services, has a high care burden, and has medical, social, psychological and economic burdens for the patient, family and society. Dementia is characterized by many disorders in cognitive functions, especially memory, thought and social skills. Progressive disorders in cognitive functions cause behavioral changes, decrease in activities of daily living, and neuropsychiatric symptoms such as anxiety and depression. evaluation and management of cognitive problems in individuals with dementia are important because they increase both the burden of care and mortality and morbidity.

Various pharmacological and non-pharmacological treatments are used in the management of incurable dementia, and the treatments are mostly aimed at reducing the behavioral and psychological symptoms of the disease. The interest in non-pharmacological treatments has increased due to the moderate effectiveness of pharmacological treatments in the management of dementia, their high level of side effects and limited applicability. One of the popular non-pharmacological treatments used to enhance memory in dementia is reminiscence therapy. In reminiscence therapy, elderly individuals are provided to recall their past experiences, these experiences are talked about, and positive emotions are shared individually or in a group. ;

Related Conditions & MeSH terms

• Dementia

• NCT number: NCT06180694
• Study type: Interventional
• Source: Amasya University
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 1, 2024
• Completion date: May 4, 2024